American Healthcare REIT (NYSE:AHR) Updates FY24 Earnings Guidance

American Healthcare REIT (NYSE:AHR) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided EPS guidance of $1.40-1.43 for the period, compared to the consensus EPS estimate of $1.26. American Healthcare REIT also updated its FY 2024 guidance to 1.400-1.430 EPS.

American Healthcare REIT Stock Performance

Shares of American Healthcare REIT stock traded up $0.25 on Friday, hitting $26.47. The company had a trading volume of 31,954 shares, compared to its average volume of 1,449,679. The stock has a 50-day moving average of $25.16 and a 200-day moving average of $19.21. The company has a quick ratio of 0.29, a current ratio of 0.29 and a debt-to-equity ratio of 0.60. American Healthcare REIT has a twelve month low of $12.63 and a twelve month high of $27.77.

American Healthcare REIT (NYSE:AHR) last released its quarterly earnings results on Tuesday, November 12th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.35). The firm had revenue of $523.81 million during the quarter, compared to analyst estimates of $474.26 million. American Healthcare REIT had a negative net margin of 1.84% and a negative return on equity of 1.96%. American Healthcare REIT’s revenue for the quarter was up 12.8% on a year-over-year basis. On average, equities research analysts anticipate that American Healthcare REIT will post 1.41 EPS for the current fiscal year.

American Healthcare REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 18th. Stockholders of record on Friday, September 20th were issued a $0.25 dividend. The ex-dividend date of this dividend was Friday, September 20th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 3.78%. American Healthcare REIT’s dividend payout ratio (DPR) is presently -208.33%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on AHR. KeyCorp lifted their price target on shares of American Healthcare REIT from $16.00 to $27.00 and gave the company an “overweight” rating in a research note on Monday, September 16th. JMP Securities upped their target price on American Healthcare REIT from $18.00 to $30.00 and gave the stock a “market outperform” rating in a report on Friday, September 20th. Bank of America increased their price target on American Healthcare REIT from $27.00 to $31.00 and gave the company a “buy” rating in a research report on Tuesday, September 24th. Truist Financial upped their price objective on American Healthcare REIT from $22.00 to $27.00 and gave the stock a “buy” rating in a research note on Friday, September 20th. Finally, Morgan Stanley raised their target price on shares of American Healthcare REIT from $17.00 to $22.00 and gave the company an “overweight” rating in a research note on Thursday, August 22nd. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $23.00.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.